Hi-Risk/Recurrent/Advanced PCa Video Chat Support – Men & Caregivers Recording, May 03, 2021
Editor’s Pick: An 80 yr old man tolerating docetaxel is an inspiration to all. Later on, practically ,do you stop treatment to allow PSA rise for screening purposes? (rd)
Topics Discussed
80+ yr old man undergoes chemo, but rash stops it; reluctant patient faces recurrence; Grade 4 Radiation Cystitis; more recurrence w. pelvic girdle RT; NGS reveals MSI-H; getting an Axumin scan thru MSKCC; In Memory of Scott Hogan; ARV110 trial fails BRCA2 patient; swollen legs leads to coming off abi; melanoma Dx to add to PCa; continuing Tx vs allowing PSA rise to see source of recurrence; bowel and bladder maintenance during salvage RT
Chat Log \
John Ivory (Private): 5:22 PM: https://www.dignityhealth.org/ourdoctors/1699772210-russell-gollard
Carlos Huerta (to Everyone): 5:25 PM: Extravasation is when a medication gets out of the vein and under your skin.
Jake Hannam (to Everyone): 5:26 PM: Extravasation is the leakage of a fluid out of its container into the surrounding area, especially blood or blood cells from vessels. In the case of inflammation, it refers to the movement of white blood cells from the capillaries to the tissues surrounding them (leukocyte extravasation, also known as diapedesis). Extravasation injury is defined as the damage caused by the efflux of solutions from a vessel into surrounding tissue spaces during intravenous infusion. The damage can extend to involve nerves, tendons, and joints and can continue for months after the initial insult.
Bruce Bocian (to Everyone): 5:37 PM: Try lavender oil
Eileen Murphy (to Everyone): 5:37 PM: How about Sarna lotion with menthol or Aveeno products?
Bruce Bocian (to Everyone): 5:38 PM: I got the lavender oil tip from the essential oil book
Bob McHugh (to Everyone): 5:57 PM: A shrink or social worker for this guy?
Herb Geller (to Organizer(s) Only): 6:03 PM: I just searched his hospital and there are no GU oncologists
William Franklin (to Everyone): 6:27 PM: I don’t want to take up time we can use to talk to you guys so I’ll put my plug in here. If you feel like ANCAN has helped you and you’d like to say something nice about us, please hop over to greatnonprofits.org, search for ANCAN, and make a comment. We would greatly appreciate it.
Rick Davis (to Everyone): 6:31 PM: You can go ot our website and just click on Testimonials too
Bruce Bocian (to Everyone): 6:42 PM: Bill, just posted my review!
Frank Fabish (to Everyone): 7:15 PM: need to sign off. Thank you all.
Carlos Huerta (to Everyone): 7:17 PM: Dont forget the old standard. Castor Oil.
Joe Gallo (to Everyone): 7:20 PM: Senakot is brand of Sena
At AnCan, we LOVE friends! And helping you get resources you need to empower you to “Be Your Own Best Advocate!” Here are some great, informative, and FREE resources from our partner CancerCare. Be sure and check them out!
Hi-Risk/Recurrent/Advanced PCa Video Chat Support – Men & Caregivers Recording, Apr 27, 2021
Editor’s Pick:The lengthy discussion about the benefits of introducing a 2nd line anti-androgen therapy is worth a listen! (rd)
Topics Discussed
PSMA scan available at U of Michigan; very small 4+4 daignosis is challenging; starting cyclophosphamide; benefits of a 2nd line anti-androgen; intermittent hormone therapy; clincal trial results vs individual response; 3rd party advice just doesn’t work!; chemo side effects inc. dry eye : repeat NGS sequencing after 18 mo.; 4+5 treatment plan after focal recurrence; Space Oar
Chat Log
Bruce Bocian (to Everyone): 3:43 PM: James Pool, Jr. Clinical Subjects Coordinator, University of Michigan Health System, 1500 E. Medical Center Drive CVC 5583 Box 5868 Ann Arbor, MI 48109 Phone: (734) 615-7391 Fax: (734) 615-1435 Email: jampool@med.umich.edu Pager: 5425
Rick Davis (to Everyone): 3:43 PM: Tx Bruce
Rick Davis (to Everyone): 3:47 PM: joeg@ancan.org Joe Gallo
Rick Davis (to Herb Geller): 4:13 PM: Herb – this is in your wheelhouse. The trial is not ‘epidemiologocal’ per se??
Herb Geller (Private): 4:15 PM: The trials were not epidemiological they were randomized
Rick Davis (to Everyone): 4:18 PM: Here’s the link for Thursday’s Larry Fong webinar on cancer immunotherapy: https://bit.ly/3thuPmq
Pat Martin (to Everyone): 4:23 PM: What kind of Gleason score was he DXed as? Sorry I was a little slow. Story of my life.
Bruce Bocian (to Everyone): 4:26 PM: Bring him on a call with you next time!!!!
Ravi (to Everyone): 4:28 PM: How do you decide you need a medical oncologist in addition to a radiation onco
Bill Franklin (to Organizer(s) Only): 4:28 PM: Anyone on the call who used Hydrogel or the SpaceOAR for radiation?
Herb Geller (to Everyone): 4:29 PM: If you have disease that is systemic, then the appropriate person is a medical oncologist. An RO would be for localized lesions only.
Bruce Bocian (to Everyone): 4:33 PM: Invite him over for a beer
Mike Yorke – Florida (to Everyone): 4:56 PM: https://www.cancercenter.com/treatment-options/radiation-therapy/external-beam-radiation
ALFRED LATIMER (Private): 4:59 PM: Looked it up. Most recent test was Guardant a year ago. positive BRAC2 Ordered by Dr. Scholz. Dr L had that test result and other earlier ones
Rick Davis (to ALFRED LATIMER): 5:10 PM: Tx for info ….. you are doing the right thing
On April 29th, we had the utmost pleasure of having the highly esteemed Dr. Lawrence Fong (Efim Guzik Distinguished Professor in Cancer Biology, UCSF. Leader, Cancer Immunotherapy Program, and Co-Leader, Cancer Immunology & Immunotherapy Program, UCSF Helen Diller Family Comprehensive Cancer Center) lead a presentation about immunotherapy for prostate cancer, from active surveillance to advanced disease.
What is immunotherapy?
“Our immune system is designed to defend us from foreign attacks, such as viruses and bacteria. Immunotherapy for cancer takes advantage of the immune system to kill cancer cells by directing immune cells to recognize cancer cells by specific proteins on their surface.”
We want to sincerely thank Dr. Fong for the excellent presentation and education he provided!
Watch this fascinating presentation here:
Special thanks to Myovant Sciences for sponsoring this webinar.
If Medicine Doesn’t Come to you, Go to the Medicine!
You know what they say about Mohammed and the Mountain …… if the mountain will not go to Mohammed, Mohammed must go to the mountain! Well it’s often like that today with cutting edge medicine – and even not so cutting edge if you live in out of the way places like Maui, HI where our Board President, Peter Kafka, resides. It’s all part of Being Your Own Best Advocate…… (rd) PS Peter has asked me to clarify, he wrote what follows – not me. But I guess most of you can figure that out!
Back in 2014 when I was first diagnosed with advanced prostate cancer, my younger son who was 38 years old at the time was in the urologist’s office with me getting the news. As I was seated on the exam table, he was standing in the corner leafing through the booklets and pamphlets about prostate cancer while we waited for the doctor to deliver the bad news. My son, holding up a booklet exclaimed to me; “Dad, this literature is older than me!” Right away we both knew we were in the WRONG place.
Unfortunately, so many men and women reside or walk into the “wrong” place when it comes to getting access to the most up to date technology in terms of treatment or diagnostic tools. Little did I know back then. I lived at that time under the illusion that the “Doctor” knew everything and would of course be up to date with the latest and greatest. Not so, as I quickly learned.
One of the great values that I have found in participating regularly in our AnCan prostate cancer support groups is the experiential reporting on all the new cutting-edge treatments and diagnostic tools that are emerging and available. Recently one of our number took advantage of the new technology of Micro Ultrasound to guide a biopsy. Apparently, this is found to be even better than the 3T multi-parametric MRI in determining just where to poke the needle and take a tissue sample, leading to a far more accurate diagnosis. It can detect small, but significant lesions within the prostate that might otherwise be missed.
The rub however, like any new advancement is that not every facility or doctor will be in the “know” or have access to such tools or treatments. Don’t I know this well, living here on the Island of Maui in the middle of the Pacific Ocean. The lesson for all of us is that we should carry a business card stating; “Have Suspicion Will Travel”. Please don’t wait for technology to come to your doorstep or for enlightenment to come to your doctor. Your life is way too important to me.
Hi-Risk/Recurrent/Advanced PCa Video Chat Support – Men & Caregivers Recording, Apr 19, 2021
Editor’s Choice: Lively discussion on mental health brought on by treatment, especially in the Chat. And later on, hot & cold tumors (rd)
Topics Discussed
Recurrence 5 years after RP; recurrence after brachy + IMRT; Provenge; Caregiver discusses depression and anxiety; prostate in teh bladdernech impacts RT choice; 2nd opinion from Dr. Morgans may change treatment; Xgeva dosing; hot vs cold tumors impact immunotherapy; end of chemo in sight; Lu177 PSMA working; cyclophosphamide; HT holiday appears over
Chat Log
Bruce Bocian (Private): 5:04 PM: Wearing my new T-shirt tonight!
Rick Davis (to Bruce Bocian): 5:06 PM: I see …. nice job! Give it a plug …..
Bruce Bocian (Private): 5:06 PM: I did before you came on.
Len Sierra (to Everyone): 5:26 PM: Antonarakis and Denmeade
Jake Hannam (to Organizer(s) Only): 5:29 PM: CT and bone scan will probably be redundant if he can get the PET/CT approved
Pat Martin (to Everyone): 5:42 PM: Good night, all. See you next week
Jeff Marchi (to Everyone): 5:45 PM: no CT or bone scan
Alan Dibble (to Everyone): 5:46 PM: Alan does not wish to ask how everyone deals with the emotional aspect of this disease. He had prostate removed, radiation therapy and now on chemo, plus injections of eligard. (Cancer spread to hips and femur after 1 year after radiation).. He goes through much anxiety and depressions. He is 69 and was diagnosed at 56 years of age. He does not wish to speak. I’m getting involved on his behalf. I’m his wife of 20 years.
Jake Hannam (to Organizer(s) Only): 5:50 PM: Alan may wish to join Speaking Freely
Jake Hannam (to Everyone): 5:56 PM: Venlafaxine is used to treat depression. It may improve your mood and energy level, and may help restore your interest in daily living. Venlafaxine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI).
Tad (to Everyone): 5:57 PM: venlafaxine = Effexor (er)
John Ivory (to Everyone): 5:57 PM: Many people use the brand name for venlafaxine, which is Effexor XR
Rick Davis (to Everyone): 6:00 PM: Let’s not push venlafaxine – we are not expert enough to do that! We have expertise in PCa – we don’t have expertise in mental health. And we know better how men respond to the PCa drugs.
Tad (to Everyone): 6:07 PM: Ok….. all I meant. isthat I have experience in mental health
John Ivory (to Everyone): 6:08 PM: Are you a physician or a therapist, Tad?
Tad (to Everyone): 6:08 PM: A lifetime of personal experience. Are there physicians here for prostate? I’m just offering help like others are
Rick Davis (to Everyone): 6:09 PM: an SSRI can effect one person well and not another. They may need an SNRI.
Tad (to Everyone): 6:10 PM: yep or maoi……or I had shock treatments, etc etc etc. just like there are generalities for prostate, there are generalities with mental….general places to start. Bipolar type 2 since 1988. Been in psych hospitals many times. Electric shock treatments. Every med there is. Best dr’s in the country. This cancer stuf has been. awalk in the park compared to having. alife with. a major mental illness. Haven’t been back here for over a year. Finally was able to get back here tonight…..but this makes me depressed. So I’ll leave. Have a nice night.
Dennis McGuire (Private): 6:24 PM: Hi Rick, Is Dr. Morgans leaving Northwestern ? Heard the end of that conversation. Thanks
Rick Davis (to Dennis McGuire): 6:24 PM: Yup – early July. She’s going to Dana-Farber.
Dennis McGuire (Private): 6:26 PM: Sorry to hear that. Great hire by Dana-Farber ! She is a Superstar. I remember she has a history with Dana-Farber in her earlier days
Rick Davis (to Everyone): 6:36 PM: https://www.fiercebiotech.com/research/epizyme-s-ezh2-blocker-boosts-immuno-oncology-response-prostate-cancer-models Tazverik
Vincent Wilmot (to Everyone): 6:38 PM: Thanks all. Have to jump off now. Will stay in touch.
Jake Hannam (to Everyone): 6:38 PM: Mark your calendars for what AnCan expects to be a humdinger of a webinar on Thursday, April 29 at 8 pm Eastern. Advisory Board Member and Co-Director of the Parker Institute for Cancer Immunotherapy at UCSF, Dr. Larry Fong, will answer “Will Immunotherapy Change Your Prostate Cancer Treatment?” . Register at https://bit.ly/3thuPmq to learn how Superman came to visit Larry!
Ken (to Everyone): 6:41 PM: Got to go… pilots telling me turn off electronics
Jake Hannam (to Everyone): 6:42 PM: Sorry. Can’t attach the flier. See our Facebook page: https://www.facebook.com/answercancer/photos/a.1872701729640708/2908943646016506/
Bill Franklin (to Organizer(s) Only): 6:43 PM: I’ve got to drop guys. Need to help my son finish up a little bit of homework so he can get to bed at a reasonable time. Take care all.
Jake Hannam (to Everyone): 6:58 PM: dexamethasone (1 mg/day in the evening) with cyclophosphamide (50 mg/day in the morning). Zofran
Ted Healy (to Everyone): 7:02 PM: Got to go folks, thank you all!
Support comes in many forms, and here at AnCan, we are so blessed to have Hannah Garrison, a fantastic MS activist, moderator for our MS Virtual Support Group, and artist.
In honor of MS Awareness Month (March) we had a phenomenal time with adaptable art of all skill levels. We used paint and old gift cards to create masterpieces. We even had adorable kids join for a family night!
Feel free to create this art project anytime (no matter what community you belong to) with the video below: (Scroll down for supply list)
Supply list:
1. Acrylic paint
2. paper plate or palette
3. old, empty gift card or old credit card – the paint will ruin it, so make sure they know it can’t be usable
4. napkins – lots!! things will get messy
5. paper – any sturdy paper – cardstock, watercolor paper, acrylic paper
6. brush – optional, for mixing colors on your paper plate/ palette
We will be offering more art related support soon, including an AnCan art gallery. If you’d like more information or have any suggestions, please email me at alexa (at) ancan.org!
For information on our peer-led video chat MULTIPLE SCLEROSIS VIRTUAL SUPPORT GROUP, click here.
To SIGN UP for the Group or any other of our AnCan Virtual Support groups, visit our Contact Us page.
Hi-Risk/Recurrent/Advanced PCa Virtual Support – Men & Caregivers Recording, Apr 13, 2021
Editor’s Choice : We learn about a partial removal of the prostate for urinary reason – a simple prostatectomy; and how this can complicate identifying whether PCa has spread. (rd)
Topics Discussed
Hawaii KP patient needs better follow-up on recurrence; a partial removal of the prostate confuses what’s going on; 80 yr man wonders how to handle recurrence; Lu177 PSMA trial experience; & … I130 PSMA trial experience together with jaw issues; cyclophosphamide oral chemo; the AUS works!! (artificial urinary sphincter); PSA still rising on ARV110 trial; experience with return of testosterone; follow-up after 4+5 RP with a positive node.
Chat Log
Rick Davis (to Everyone): 3:03 PM: OMG …… Don Price – the Mouse returns!! Bob Bordiga also coming out the woodwork
Don Price (to Everyone): 3:06 PM: Si…sorry to have been away so long.
John Ivory (to Everyone): 3:45 PM: https://cancer.osu.edu/find-a-doctor/search-physician-directory/anish-b-parikh Pat Martin (to Everyone): 3:46 PM: Any biopsies?
Jake Hannam (to Everyone): 3:51 PM: thanks john
Pat Martin (to Everyone): 3:53 PM: What Gleason score?
John Ivory (to Everyone): 3:53 PM: he said 4+4
Pat Martin (to Everyone): 3:54 PM: Thanks. I missed that
W Klass Toronto (to Everyone): 3:56 PM: Need to leave. Thanks for the invite.
Pat Martin (to Everyone): 3:57 PM: I was looking forward to hearing from you.
Jake Hannam (to Everyone): 3:57 PM: thanks for joining us. Come back soon!
Herb Geller (to Organizer(s) Only): 4:03 PM: I just got an e-mail from Collins at Gt saying my PSA yesterday was 1.4, and that was after I did stationary bicycle. The previous GT number was 1.8!
Pat Martin (to Everyone): 4:08 PM: heading out. See all next week.
John Ivory (to Everyone): 4:16 PM: I’ve go to run to another meeting. Good to see everyone!
Russ (to Everyone): 4:25 PM: Heading out as well. Have a good night!
Bob (to Everyone): 4:30 PM: Is an axumin scan the same as a PSMA PET with Galium 68?
Jake Hannam (to Everyone): 4:30 PM: oral chemotherapy drug called cyclophosphamide (Cytoxan)
Herb Geller (to Organizer(s) Only): 4:30 PM: No, it uses a different tracer from PSMA. Axumin uses a different tracer
Len Sierra (to Everyone): 4:31 PM: Bob, no, PSMA-PET is more sensitive than Axumin
Rick Davis (to Everyone): 4:36 PM: cyclophosphamide https://pubmed.ncbi.nlm.nih.gov/31399784/
Bob (to Everyone): 4:40 PM: Does anyone have experience with BiPolar ADT? If so, did it work?
Rick Davis (to Everyone): 4:41 PM: Bob – we have a webinar on BAT … search for Denmeade on our website https://ancan.org
Rick Davis (to Everyone): 4:42 PM: Anecdotally we only see short term results from BAT, but JH is reporting better results. Some of our guys have had more conversations with JH. This is a longer discussion than the chat window.
Bob (to Everyone): 4:43 PM: Thank you everyone. I have to leave due to a 1:45appointment which was previously scheduled.
Jake Hannam (to Everyone): 4:44 PM: ARV-110
Jeff Marchi (Private): 4:48 PM: you asked whether Santa Clara is where the medoc is located. when I had my prostate removed I had to drive from San Francisco to San Jose. that is where the surgeons are located. must be where medoc is located
Rick Davis (to Jeff Marchi): 4:50 PM: No he’s mid-Peninsula
Herb Geller (to Everyone): 5:16 PM: I gotta go. See you on Monday
Len Sierra (to Everyone): 5:23 PM: Goodnight, fellas. See you next week.
Here are some thoughts from our own Howard Wolinsky. He is a Chicago-based medical writer and author. His new book is “Contain and Eliminate: The American Medical Association’s Conspiracy to Destroy Chiropractic.” For more information, go to Containandeliminate.com. He also contributes a blog, “A Patient’s Journey,” to MedPageToday.com. He has been on active surveillance for 10 years.
Active surveillance for men with low-risk cancers has been the Rodney Dangerfield of urology. We men on AS — close monitoring of our cancers — get little to no respect from men being treated for prostate cancer who can experience a host of serious side effects.
AS has experienced gains over the past five years. The American Urological Association in 2017 stated in new guidelines that clinicians should recommend active surveillance as “the best available care option for very low-risk localized prostate cancer patients. (Strong Recommendation; Evidence Level: Grade A).”
This is a far cry from when I was diagnosed in December 2010, and my first urologist told me he could cure my cancer — a tiny Gleason 6 in a single core — “next Tuesday” when he had an opening in his OR. Back then, 6–10% of men like me opted for AS. Or, to put it another way, 90–94% sought “definitive” treatments, mostly radical prostatectomies.
A new generation of urologists, following the guidelines, is increasingly resisting the urge to perform surgery and rather recommends that men with low-risk Gleason scores of 3+3 and some men with favorable intermediate-risk Gleason scores of 3+4 go on AS.
There has been a surge in the past five years in the proportion of American men opting for AS. Some experts estimate that as many as 50–60% of eligible men now choose AS. (Again, 40–50% still opt for prostatectomies or radiation, a contrast from 90% who opt for AS in Sweden and the Netherlands.)
In May 2017, I described in my MedPageToday blog the lack of support services for men on AS. The philosophy then was to combine men on the full range of diagnoses, from very low-risk to advanced cancers, and treatments.
However, the voices of men worried about their next biopsy or MRI could be drowned out by those of men with impotence or incontinence as collateral damage from radical surgery, to those with hot flashes from hormone therapy, or “brain fog” from chemotherapy.
Men with low-risk cancer attend these meetings and often don’t return.
Some think these side effects are their future. But they’re not. About 50% of men on AS eventually end up being treated, though frequently they switch to treatments because of anxiety rather than the disease progressing.
Some men experience anxious surveillance; they may have low-risk disease but they can’t co-exist any longer with a cancer that can be cut out or zapped with radiation or lasers.
I encountered outright hostility when I suggested in my blog four years ago that separate support groups be created for men on AS.
One group, known as the “warriors,” argued all men with prostate cancer are in this together in what they like to call the “reluctant brotherhood.” But these. men with aggressive treatments and diseases may not realize men with low-risk disease are being scared off and want to stay away from the brotherhood altogether.
It still isn’t widely acknowledged that there is a cultural divide between these groups of men with very different diseases and side effects, different views of their diseases, and different emotional needs.
Some of the support and advocacy organizations have been trying to meet this need for men on AS. Groups, including AnCan/Us Too, Active Surveillance Patients International, Cancer ABCs, Malecare, Inspire (a virtual group from Us TOO International), Prostate Cancer Research Institute, and ZERO — The End of Prostate Cancer have been making some strides with virtual, asynchronous and (until COVID-19) in-person support groups.
About a year and a half ago, I helped start a monthly virtual support group for AnCan and UsToo believed to be the first of its kind in the U.S. The group has grown to a weekly meeting. We hold webinars featuring leading experts on AS that draw hundreds of men virtually and hundreds more on video replay,
At last, AS seemed to be finding its place in the support sun. Then, I encountered negative attitudes on the part of people who ought to know better — support group leaders.
One impatient leader in effect asked me when men on AS would just grow up, “bite the bullet,” put on their big boy pants and stop whining about biopsies that could save their lives. But the man who said this had undergone hormonal treatment and didn’t quite understand that men on AS are not “whiners” or “crybabies” but rather are coping with their own problems.
I told him there is a cultural gap between men who were being treated and low-risk men like me. Men with more higher-grade cancers who are being treated may be fighting for their lives while those on AS are worrying about more fundamental issues such as “When should I have a confirmatory biopsy” or “Is gadolinium contrast dangerous?” that are just as real to them.
I was frustrated about another incident recently that demonstrates how little respect AS may be getting from some men with higher Gleason scores and collateral damage from treatment.
As an Us Too group leader, I got a note from HQ seeking group leaders willing to talk in pop-up support groups about such topics as surgery, radiation, hormone therapy, and helping the newly diagnosed and caregivers. Us Too made the request on behalf of ZERO, which wanted to include sessions at its annual Summit this year.
I read the list over. ZERO, a savvy organization I have worked with, omitted active surveillance as a topic. I pointed this out and ZERO graciously added a support “lounge” devoted to AS. An oversight, sure, but no slight intended. Three of us AS support group moderators volunteered to participate.
I was stunned at what happened at the session. We had about 25 attendees. Apparently, most had been treated or were considering treatment for more advanced cancers. We did what we could to help and refer the men to support groups more suited to them.
We suspected there were some men on AS lurking but not talking.
One very vocal group leader represented a prostate cancer support group for all-comers. He said he had undergone a radical prostatectomy decades ago. He said he knew about AS but admitted he wasn’t much of a fan.
I gather he thought that aggressive therapy was inevitable so why not get it over with. He insisted his group did what it could to support men on AS.
But he said he found these men to be scared rabbits (my term). I can understand why. They were attending a support group geared toward men coping with severe side effects and those fighting for their lives run by a leader who didn’t really believe in AS as an option.
Good intentions gone awry.
I suspect there is a lot of this going on in the support world. I wonder how many men with low-risk or favorable intermediate-risk prostate cancer attend these groups and are steered into undergoing prostatectomies or radiation therapy when none is needed — at least not immediately.
I contrast these AS skeptics with my friend Bob Allan, a support group leader from Prostate Cancer Support Canada/Burlington in suburban Toronto. Allan was treated with radiation years ago and has fared well. But he supports AS as an option and regularly attends our AnCan/UsToo virtual meetings to learn about the latest on AS to share with his members.
It’s time to end this undeclared culture war. I think many support group leaders need to be educated about AS especially since the proportion of men with prostate cancer opting for AS is on the rise. Or these support group leaders need to refer AS patients to support groups with expertise in active surveillance.
Men on AS will be better served by taking these approaches than suffering in silence in their groups.
On April 7th, we had a packed house to see Dr. Andres F. Correa (Fox Chase Cancer Center’s Department of Surgery in the Urologic Oncology Division) at our Active Surveillance Virtual Support Group.
He briefed our community on two of the hottest technologies in the field: transperineal biopsies and micro-ultrasound. He explained that TP biopsies virtually eliminate deadly septic infections and also offer the urologist easier access to the anterior section of the prostate gland. Correa said his group uses micro-ultrasound imaging of the prostate as a complement to mpMRI imaging.
We want to thank Dr. Correa for providing such helpful information!
Watch this presentation here:
To view the slides from this presentation, click here.
For information on our peer-led video chat ACTIVE SURVEILLANCE PROSTATE CANCER VIRTUAL SUPPORT GROUP, click here.
To SIGN UP for the Group or any other of our AnCan Virtual Support groups, visit our Contact Us page.